Evidence map›Paper›PMID 36943065›Full record

ArticleAntimicrobial agents and chemotherapy2023

Drug Susceptibility Profiling of

Angelika Proskurnicka, Kinga Żupnik, Zofia Bakuła, Mateusz Iskra, Uwe Rösler, Tomasz Jagielski

Open access · hybridAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Experimental protothecosis in a murine model.PLoS neglected tropical diseases · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Successful Treatment of Cutaneous Protothecosis Due toClinical, cosmetic and investigational dermatology · 2024
    Article
  7. Open forum infectious diseases · 2023
    Article
  8. Article
  9. Protothecosis in Dogs: A Narrative Review.Journal of veterinary internal medicine
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Angelika ProskurnickaDepartment of Medical Microbiology, Institute of Microbiology, Faculty of Biology, University of Warsaw, Warsaw, Poland.ORCID 0000-0001-6714-3354
Kinga ŻupnikDepartment of Medical Microbiology, Institute of Microbiology, Faculty of Biology, University of Warsaw, Warsaw, Poland.
Zofia BakułaDepartment of Medical Microbiology, Institute of Microbiology, Faculty of Biology, University of Warsaw, Warsaw, Poland.ORCID 0000-0001-7560-2100
Mateusz IskraDepartment of Medical Microbiology, Institute of Microbiology, Faculty of Biology, University of Warsaw, Warsaw, Poland.
Uwe RöslerInstitute for Animal Hygiene and Environmental Health, Freie Universität Berlin, Berlin, Germany.
Tomasz JagielskiDepartment of Medical Microbiology, Institute of Microbiology, Faculty of Biology, University of Warsaw, Warsaw, Poland.ORCID 0000-0001-9553-5742
University of Warsaw · PLFreie Universität Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ProtothecaSkin Diseases, InfectiousAmphotericin BFluconazoleHumansMaleAmphotericin BFluconazolealgicidal effectazolesefinaconazoleluliconazolePrototheca speciesprotothecosisravuconazole

Identifiers

PMID36943065
PMCPMC10112244
OpenAlexW4328049161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.